Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Accounting and Finance

President and Chief Executive Officer, Member Board of Directors

Chief Financial Officer

Intellia Therapeutics Completes Enrollment in the Global Phase 3 HAELO Study of Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema

Intellia Therapeutics completes enrollment in Phase 3 HAELO study of Ionov-z

Intellia completes global Phase 3 HAELO study enrollment for Lonvo-Z in hereditary angioedema

Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday

Sr. Director, R&D Quality and Compliance

Intellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Senior Director of R&D Quality Assurance will lead the R&D QA function, ensuring compliance with Good Clinical Practice and other regulatory standards while collaborating with senior management and stakeholders to enhance quality initiatives across clinical studies.

Sign up with Google

Sign in with Google